Jpmorgan Chase & CO Cronos Group Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Cronos Group Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 3,433 shares of CRON stock, worth $7,312. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,433
Previous 3,433
-0.0%
Holding current value
$7,312
Previous $7,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CRON
# of Institutions
210Shares Held
47.5MCall Options Held
3.38MPut Options Held
1.6M-
Chescapmanager LLC Baltimore, MD7.95MShares$16.9 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.48MShares$15.9 Million0.0% of portfolio
-
ETF Managers Group, LLC Summit, NJ5.53MShares$11.8 Million0.39% of portfolio
-
Toroso Investments, LLC Massapequa, NY5.03MShares$10.7 Million0.13% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.62MShares$5.58 Million0.0% of portfolio
About Cronos Group Inc.
- Ticker CRON
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 377,896,000
- Market Cap $805M
- Description
- Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of...